Mohan, N.; Luo, X.; Shen, Y.; Olson, Z.; Agrawal, A.; Endo, Y.; Rotstein, D.S.; Pelosof, L.C.; Wu, W.J.
A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action. Cancers 2021, 13, 1027.
https://doi.org/10.3390/cancers13051027
AMA Style
Mohan N, Luo X, Shen Y, Olson Z, Agrawal A, Endo Y, Rotstein DS, Pelosof LC, Wu WJ.
A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action. Cancers. 2021; 13(5):1027.
https://doi.org/10.3390/cancers13051027
Chicago/Turabian Style
Mohan, Nishant, Xiao Luo, Yi Shen, Zachary Olson, Atul Agrawal, Yukinori Endo, David S. Rotstein, Lorraine C. Pelosof, and Wen Jin Wu.
2021. "A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action" Cancers 13, no. 5: 1027.
https://doi.org/10.3390/cancers13051027
APA Style
Mohan, N., Luo, X., Shen, Y., Olson, Z., Agrawal, A., Endo, Y., Rotstein, D. S., Pelosof, L. C., & Wu, W. J.
(2021). A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action. Cancers, 13(5), 1027.
https://doi.org/10.3390/cancers13051027